Drug Type Gene therapy |
Synonyms SBI 201, SBI201 |
Target |
Action inhibitors |
Mechanism HIF-1α inhibitors(Hypoxia-inducible factor 1 alpha inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Peripheral Arterial Disease | Preclinical | South Korea | 01 Feb 2024 |





